Skip to main content

Ultragenyx Pharmaceutical Inc.

RARE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001515673

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Ultragenyx Pharmaceutical Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
235
+15 vs. Q3 2021
Shares held
67.7M
+1.19M (+1.8%) vs. Q3 2021
Total value
$5.69B
−$305.1M (−5.1%) vs. Q3 2021
New holders
35
95 more added
Sold out
20
70 more reduced

3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 235 institutions
Q1 2021: 255 institutionsQ2 2021: 242 institutionsQ3 2021: 223 institutionsQ4 2021: 235 institutionsQ1 2022: 240 institutionsQ2 2022: 225 institutionsQ3 2022: 233 institutionsQ4 2022: 228 institutionsQ1 2023: 230 institutionsQ2 2023: 243 institutionsQ3 2023: 221 institutionsQ4 2023: 237 institutionsQ1 2024: 270 institutionsQ2 2024: 275 institutionsQ3 2024: 302 institutionsQ4 2024: 314 institutionsQ1 2025: 301 institutionsQ2 2025: 311 institutionsQ3 2025: 303 institutionsQ4 2025: 288 institutionsQ1 2026: 298 institutionsQ2 2026: 311 institutions
Value heldQ4 2021: $5.69B
Q1 2021: $7.73BQ2 2021: $6.24BQ3 2021: $6.01BQ4 2021: $5.69BQ1 2022: $4.87BQ2 2022: $4.03BQ3 2022: $2.81BQ4 2022: $3.15BQ1 2023: $2.76BQ2 2023: $3.21BQ3 2023: $2.52BQ4 2023: $3.84BQ1 2024: $3.73BQ2 2024: $3.63BQ3 2024: $4.83BQ4 2024: $3.68BQ1 2025: $3.25BQ2 2025: $3.42BQ3 2025: $2.87BQ4 2025: $2.16BQ1 2026: $2.05BQ2 2026: $3.55B
Institutions holding RARE and their total value by quarter
QuarterHoldersValue
Q2 2026311$3.55B
Q1 2026298$2.05B
Q4 2025288$2.16B
Q3 2025303$2.87B
Q2 2025311$3.42B
Q1 2025301$3.25B
Q4 2024314$3.68B
Q3 2024302$4.83B
Q2 2024275$3.63B
Q1 2024270$3.73B
Q4 2023237$3.84B
Q3 2023221$2.52B
Q2 2023243$3.21B
Q1 2023230$2.76B
Q4 2022228$3.15B
Q3 2022233$2.81B
Q2 2022225$4.03B
Q1 2022240$4.87B
Q4 2021235$5.69B
Q3 2021223$6.01B
Q2 2021242$6.24B
Q1 2021255$7.73B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Ultragenyx Pharmaceutical Inc.; share changes are against Q3 2021.

Institutions holding RARE in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Dimensional Fund Advisors LP322,051$27.1M0.01%+95,795+42.3%Added
Northern Trust Corp339,549$28.6M0.00%−3,264−1.0%Reduced
TD Asset Management Inc373,771$31.4M0.03%+129,824+53.2%Added
First Light Asset Management, LLC411,313$34.6M2.48%−29,846−6.8%Reduced
Capital Research Global Investors425,160$35.8M0.01%−2,936,632−87.4%Reduced
Point72 Asset Management, L.P.425,874$35.8M0.16%+85,500+25.1%Added
Baker Bros. Advisors LP444,444$37.4M0.18%00.0%Unchanged
Deutsche Bank AG455,333$38.3M0.02%+99,547+28.0%Added
Suvretta Capital Management, LLC485,242$40.8M0.79%+485,242New
Charles Schwab Investment Management Inc526,183$44.2M0.01%+12,334+2.4%Added
D. E. Shaw & Co., Inc.546,591$46.0M0.06%+70,884+14.9%Added
Invesco Ltd.560,140$47.1M0.01%−143,224−20.4%Reduced
Norges Bank621,576$52.3M0.01%+59,038+10.5%Added
Adage Capital Partners GP, L.L.C.700,000$58.9M0.11%+80,000+12.9%Added
Avidity Partners Management LP700,000$58.9M1.25%+245,000+53.8%Added
Goldman Sachs Group Inc725,678$61.0M0.01%+219,470+43.4%Added
First Trust Advisors LP742,641$62.4M0.06%+25,533+3.6%Added
Bank of New York Mellon Corp849,543$71.4M0.01%−14,802−1.7%Reduced
Geode Capital Management, LLC876,956$73.7M0.01%+30,889+3.7%Added
Rock Springs Capital Management LP883,921$74.3M1.72%+82,812+10.3%Added
Macquarie Group Ltd924,172$77.7M0.06%−7,097−0.8%Reduced
FMR LLC1,291,379$108.6M0.01%+130,394+11.2%Added
Alliancebernstein L.P.1,308,156$110.0M0.04%+152,002+13.1%Added
RTW Investments, LP1,373,284$115.5M1.69%+1,373,284New
Citadel Advisors LLC1,443,447$121.4M0.13%−39,703−2.7%Reduced
State Street Corp1,678,841$141.2M0.01%+204,976+13.9%Added
Alkeon Capital Management LLC2,308,130$194.1M0.66%00.0%Unchanged
Capital World Investors2,766,844$232.7M0.04%−170.0%Reduced
Clearbridge Investments, LLC2,778,859$233.7M0.16%+413,238+17.5%Added
Wellington Management Group LLP2,877,403$242.0M0.04%+369,128+14.7%Added
BlackRock Inc.3,484,652$293.0M0.01%+34,099+1.0%Added
Federated Hermes, Inc.3,986,870$335.3M0.63%−1620.0%Reduced
Capital International Investors5,369,774$451.5M0.10%−295,419−5.2%Reduced
Vanguard Group Inc5,920,568$497.9M0.01%+45,737+0.8%Added
Price T Rowe Associates Inc11,525,089$969.1M0.09%+66,043+0.6%Added
Two Sigma Advisers, LP0$00.00%−69,400−100.0%Sold out
Atika Capital Management LLC0$00.00%−39,700−100.0%Sold out
ClariVest Asset Management LLC0$00.00%−26,908−100.0%Sold out
Two Sigma Investments, LP0$00.00%−25,900−100.0%Sold out
Beck Bode, LLC0$00.00%−14,990−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−13,382−100.0%Sold out
Quantitative Investment Management, LLC0$00.00%−10,078−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−9,670−100.0%Sold out
Maverick Capital LtdSuperinvestorMaverick Capital0$00.00%−5,861−100.0%Sold out
Echo Street Capital Management LLC0$00.00%−4,634−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−3,553−100.0%Sold out
Neo Ivy Capital Management0$00.00%−3,864−100.0%Sold out
EFG Asset Management (Americas) Corp.0$00.00%−2,979−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−2,502−100.0%Sold out
Cim Investment Mangement Inc0$00.00%−2,370−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−351−100.0%Sold out
HighMark Wealth Management LLC0$00.00%−209−100.0%Sold out
Capital Advisory Group Advisory Services, LLC0$00.00%−150−100.0%Sold out
Meridian Wealth Partners, LLC0$00.00%−13−100.0%Sold out
Exane Derivatives0$00.00%−11−100.0%Sold out
Marshall Wace North America L.P.––––Not filed
Berman Capital Advisors, LLC––––Not filed
Wealth Quarterback LLC––––Not filed